Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1974 1
1975 1
1976 1
1978 1
1979 3
1980 2
1981 3
1982 2
1983 2
1984 4
1985 1
1986 2
1987 2
1988 2
1989 8
1990 7
1991 5
1992 3
1993 13
1994 7
1995 14
1996 6
1997 9
1998 5
1999 17
2000 11
2001 7
2002 8
2003 10
2004 9
2005 10
2006 11
2007 16
2008 11
2009 9
2010 13
2011 15
2012 12
2013 15
2014 17
2015 12
2016 13
2017 14
2018 7
2019 8
2020 13
2021 27
2022 44
2023 34
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

436 results

Results by year

Filters applied: . Clear all
Page 1
Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection.
Segal-Maurer S, DeJesus E, Stellbrink HJ, Castagna A, Richmond GJ, Sinclair GI, Siripassorn K, Ruane PJ, Berhe M, Wang H, Margot NA, Dvory-Sobol H, Hyland RH, Brainard DM, Rhee MS, Baeten JM, Molina JM; CAPELLA Study Investigators. Segal-Maurer S, et al. N Engl J Med. 2022 May 12;386(19):1793-1803. doi: 10.1056/NEJMoa2115542. N Engl J Med. 2022. PMID: 35544387 Clinical Trial.
Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial.
Ogbuagu O, Segal-Maurer S, Ratanasuwan W, Avihingsanon A, Brinson C, Workowski K, Antinori A, Yazdanpanah Y, Trottier B, Wang H, Margot N, Dvory-Sobol H, Rhee MS, Baeten JM, Molina JM; GS-US-200-4625 investigators. Ogbuagu O, et al. Lancet HIV. 2023 Aug;10(8):e497-e505. doi: 10.1016/S2352-3018(23)00113-3. Epub 2023 Jul 11. Lancet HIV. 2023. PMID: 37451297 Clinical Trial.
Five-minute test to prevent postcardiotomy reexploration.
Kunioka S, Shirasaka T, Narita M, Shibagaki K, Kikuchi Y, Saijo Y, Kamiya H. Kunioka S, et al. Among authors: shirasaka t. JTCVS Tech. 2022 Jan 19;12:121-129. doi: 10.1016/j.xjtc.2021.08.049. eCollection 2022 Apr. JTCVS Tech. 2022. PMID: 35403041 Free PMC article.
The MMR question.
Iizuka M, Itou H, Chiba M, Shirasaka T, Watanabe S. Iizuka M, et al. Among authors: shirasaka t. Lancet. 2000 Jul 8;356(9224):160. doi: 10.1016/S0140-6736(00)02459-4. Lancet. 2000. PMID: 10963263 No abstract available.
[Pharmacokinetics of S-1].
Hirata K, Horikoshi N, Tominaga K, Sohma K, Yamaguchi K, Okazaki M, Furuhata T, Sasaki K, Nakano Y, Ishizuka H, Yamada Y, Uno S, Taguchi T, Yamamitsu S, Shirasaka T. Hirata K, et al. Among authors: shirasaka t. Gan To Kagaku Ryoho. 2006 Jun;33 Suppl 1:27-35. Gan To Kagaku Ryoho. 2006. PMID: 16897969 Review. Japanese.
S-1 as a core anticancer fluoropyrimidine agent.
Miura K, Shirasaka T, Yamaue H, Sasaki I. Miura K, et al. Among authors: shirasaka t. Expert Opin Drug Deliv. 2012 Mar;9(3):273-86. doi: 10.1517/17425247.2012.652945. Epub 2012 Jan 11. Expert Opin Drug Deliv. 2012. PMID: 22235991 Review.
Cardiovascular effects of leptin and orexins.
Shirasaka T, Takasaki M, Kannan H. Shirasaka T, et al. Am J Physiol Regul Integr Comp Physiol. 2003 Mar;284(3):R639-51. doi: 10.1152/ajpregu.00359.2002. Am J Physiol Regul Integr Comp Physiol. 2003. PMID: 12571072 Free article. Review.
Triplex vascular prostheses elongation in post-operative course.
Narita M, Shirasaka T, Ushioda R, Kamiya H. Narita M, et al. Among authors: shirasaka t. J Surg Case Rep. 2022 Jun 17;2022(6):rjac255. doi: 10.1093/jscr/rjac255. eCollection 2022 Jun. J Surg Case Rep. 2022. PMID: 36284732 Free PMC article.
436 results